Board

Management Team

Greg Blake

VP - Global Head of Commercial and Partnering

As VP - Global Head of Commercial and Partnering at Zelira Therapeutics, Greg brings extensive experience in the pharmaceutical and biotech sectors both within Australia and interna­tionally. Greg has been involved in the strategic development and commercialisation of a number of products across a range of therapeutic categories. Throughout his near 20 years working in healthcare Greg has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch critical pathway and commercialisation planning for both domestic and international markets. As Regional Marketing Lead with Mundipharma International, Greg successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication. Greg has held leadership roles at large multinationals (J&J and CSL) and publicly-listed biotech start-ups.

Dr Meghan Thomas

VP of Clinical Programs and Operations

Dr Thomas is VP of Clinical Programs and Operations at Zelira Therapeutics and holds a PhD in experimental and regenerative neuroscience. Meghan has developed a unique experience that spans academic research, public health service strategy and planning, and research ethics and governance and has a proven track record in leading and managing research programs in a large and complex organisation. Her experience ideally positions her to oversee Zelira’s R&D pre-clinical programs and clinical trials.

At Zelira, Dr Thomas also oversees commercial manufacturing operations, regulatory affairs requirements and contributes to Zelira’s substantial patent portfolio. Meghan has been instrumental in launching three medicinal cannabis products with attached clinical data for Australian patients.

Meghan is on the AusBiotech WA State Committee and is part of the Medicinal Cannabis Industry Australia (MCIA) Research Working Group and MCIA Standards Working Group.

Rahul Ganesan

VP of Finance and Accounting

Rahul is VP of Finance and Accounting at Zelira Therapeutics. He brings to the company financial experience across a number of industries and a vision for directing and aligning team goals with company strategy. Rahul has over 20 years of experience in accounting and finance. He started his career working at the Big 4 accountancy firms and proceeded to hold leadership positions in functional areas ranging from Controllership to FP&A.

Start typing and press Enter to search

Shopping Cart